Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Filion KB, Lix LM, Yu OHY, et al.
BMJ. 2020;370:m3342
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Filion KB, Lix LM, Yu OHY, et al.
BMJ. 2020;370:m3342
Leggi
Jayedi A, Soltani S, Zargar MS, et al.
BMJ. 2020;370:m3324
Leggi
Heerspink HJL, Stefànsson BV, Correa-Rotter R, et al.
N Engl J Med. Pub. online 24 September 2020
Leggi
Giorda CB, Pisani F, De Micheli A, Ponzani P, Russo G, Guaita G, Zilich R, Musacchio N; Associazione Medici Diabetologi (AMD) Annals Study Group
BMJ Open Diabetes Res Care. 2020;8(1):e001362
Leggi
Groop P-H, Dandona P, Phillip M, et al.
The Lancet Diabetes & Endocrinology. 2020;8(10):845-54
Leggi
Munshi MN, Meneilly GS, Rodríguez-Mañas L, et al.
The Lancet Diabetes & Endocrinology. 2020;8(10):855-86
Leggi
Feig DS, Donovan LE, Zinman B, et al.
The Lancet Diabetes & Endocrinology. 2020;8(10):834-44
Leggi
Fan Y, Shen Y, Zhou J, et al.
Diabetes Care. 2020 dc201615
Leggi
Cravalho CKL, Meyers AG, Mabundo LS, et al.
Diabetologia. 2020,63,2194-204
Leggi
Atkinson MA, Campbell-Thompson M, Kusmartseva I, Kaestner KH
Diabetologia. 2020,63,1966-73
Leggi